BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $286.23m
- -$272.44m
- $72.59m
U.S. STOCKS ON THE MOVE-Graphite Bio, Leggett & Platt, Nauticus Robotics
U.S. STOCKS ON THE MOVE-Nike, Nikola, Trupanion
Graphite Bio announces CFO exit, shares fall
Bicycle Therapeutics names new CFO, shares fall
Brief: Bicycle Therapeutics Files For Offering Of Up To $150 Mln ADSs
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners
Brief: Bayer And Bicycle Therapeutics Enter Strategic Collaboration For Development Of Radiotherapy Drug Candidates
Bicycle Therapeutics rises on cancer radiotherapy drug alliance with Bayer
Bayer, Bicycle Therapeutics in cancer radiotherapy drug alliance
Bicycle Therapeutics PLC reports results for the quarter ended in March - Earnings Summary
Brief: Bicycle Therapeutics Says Cash Position Of $293.8 Million At March 31, Excludes $50 Million Upfront Payment From Novartis, Expected To Provide Financial Runway Into 2025
Bicycle Therapeutics PLC expected to post a loss of $1.07 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, nickel stocks, gold miners
U.S. STOCKS ON THE MOVE-Oscar Health, Walgreens Boots, Alibaba Group
Bicycle Therapeutics pedals higher after partnering with Novartis
Brief: Bicycle Therapeutics's Cash Position Of $339.2 Mln, To Provide Financial Runway
Bicycle Therapeutics PLC reports results for the quarter ended in December - Earnings Summary
Bicycle Therapeutics PLC expected to post a loss of $1.06 a share - Earnings Preview